Management of fever in neutropenic patients with acute leukemia: Current role of ceftazidime plus amikacin as empiric therapy

Journal of Chemotherapy

Volumn 12, Issue 3, 2000, Pages 232-239

  Fanci, Rosa ^b   Paci, C ^c   Martinez, R L ^c   Fabbri, A ^c   Pecile, P ^a   Leoni, F ^c   Longo, G ^c  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b Division of Hematology   (Italy)

^c NONE

Author keywords

Acute leukemia; Antibacterial therapy; Ceftazidime; Empiric therapy; Neutropenic patients

Indexed keywords

AMIKACIN; ANTIFUNGAL AGENT; CEFTAZIDIME; CIPROFLOXACIN; GLYCOPEPTIDE; ITRACONAZOLE; PYRROLE; QUINOLONE DERIVATIVE;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; DRUG EFFICACY; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; GRAM NEGATIVE BACTERIUM; HUMAN; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUTROPENIA; RASH; TREATMENT OUTCOME; VOMITING;

EID: 0034123884     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2000.12.3.232     Document Type: Article

References (14)

1. 1 Chang HY, Rodriguez V, Narboni G, Bodey GP, Luna MA, Freireich EJ. Causes of death in adults with acute leukemia. Medicine 1976; 55: 259-268.
2. 2 Feld R, Bodey GP. Infections in patients with malignant lymphoma treated with combination chemotherapy. Cancer 1977; 39: 1018-1025.
3. 3 EORTC International Antimicrobial Therapy Cooperative Group. Gram-positive bacteremia in granulocytopenic cancer patients. Eur J Cancer 1990; 26: 569-574.
4. 4 EORTC International Antimicrobial Therapy Cooperative Group. Efficacy and toxicity of single daily dose of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. Ann Intern Med 1993; 119: 584-593.
5. 5 Pizzo PA. Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 1993; 328: 1323-1332.
6. 6 Pizzo PA, Hathorn JW, Hiemenz J, et al. A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. N Engl J Med 1986; 315: 552-558.
7. 7 Kinsey SE, Machin SJ, Goldstone AH. Ceftazidime monotherapy is as effective as ceftazidime combined with gentamicin in the treatment of febrile neutropenic patients. J Hosp Infect 1990; 15 (Suppl A): 49-53.
8. 8 Freifeld AG, Walsh T, Marshall D, et al. Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem. J Clin Oncol 1995; 13: 165-176.
9. 9 Gold HS, Moellering RC. Antimicrobial-drug resistance. N Engl J Med 1996; 335: 1445-1453.
10. 10 Swartz M. Use of antimicrobial agents and drug resistance. N Engl J Med 1997; 337: 491-492.
11. 11 Koll BS, Brown AE. The changing epidemiology for infections at cancer hospitals. Clin Infect Dis 1993; 2, Suppl 17: 322-327.
12. 12 Aquino VM, Pappo A, Bachanan GR, Tkaczewski I, Mustafa MM. The changing epidemiology of bacteremia in neutropenic children with cancer. Ped Infect Dis J 1995; 14: 140-143.
13. 13 Viscoli C. Planned progressive antimicrobial therapy in neutropenic patients. Br J Haematol 1998; 102: 879-888.
14. 14 Fanci R, Rossi Ferrini P. II trattamento antibiotico delle infezioni batteriche nei pazienti neutropenici. 35°Congresso Nazionale Societa Italiana di Ematologia, Cernobbio, (Como), 10-13 Settembre 1995.